Summary
The chronotropic effects of dopamine were studied in the conscious dog with chronic A-V block. Dopamine at 12.5–200 μg/kg and 12.5–50 μg/kg/min lowered atrial rate independently of dose. After blockade of muscarine receptors or alpha-adrenoceptors, it raised atrial rate. After blockade of dopamine receptors, dopamine still lowered atrial rate, and did so dose-relatedly after blockade of beta-adrenoceptors. It raised ventricular rate, and at high doses also induced ventricular rhythm disorders. Blockade of muscarine receptors enhanced the ventricular cardioaccelerator effect of dopamine (P<0.025) at 100 μg/kg, while blockade of alpha-adrenoceptors reduced it (P<0.05). Blockade of dopamine receptors did not modify this effect, but blockade of beta-adrenoceptors reversed it. Dopamine at 25–200 μg/kg raised mean blood pressure. This effect was enhanced by blockade of muscarine receptors, reversed by blockade of alpha-adrenoceptors, and was unaffected by blockade of beta-adrenoceptors or dopamine receptors. These results show that the atrial cardiomoderator effect of dopamine is a vagal reflex response to its hypertensive action, and that it is limited by its direct beta-adrenergic stimulating action. They also show that the ventricular cardioaccelerator effect of dopamine is attenuated by a reflex vagal depressor effect consequent to the induced hypertension. No evidence was found for the existence of positive chronotropic dopamine receptors in either atria or ventricles.
Similar content being viewed by others
References
Avery GJ, Spotnitz HM, Rose EA, Malm JR, Hoffman BF (1979) Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effect of isoproterenol, dopamine and epinephrine in acute propranolol administration. J Thorac Cardiovasc Surg 77:267–276
Barrett AM, Carter J (1970) Comparative chronotropic activity of beta-adrenoceptive antagonists. Br J Pharmacol 40:373–381
Bloomberg ML, Bergman H, Sheiner NM (1970) A technique of chronic arterial catheterization in dogs. J Cardiovasc Surg 11:137–140
Boucher M (1981) Les récepteurs alpha-adrénergiques cardiaques. J Pharmacol 12:111–121
Boucher M, Duchêne-Marullaz P (1980) Acebutolol, metoprolol and propranolol in conscious dogs with chronic heart-block: chronotropic effects and relation between depression of ventricular activity and beta-adrenoceptor blocking potency. Br J Pharmacol 70:335–340
Boucher M, Duchêne-Marullaz P (1982) Effets chronotropes négatifs de la noradrénaline et de la dopamine chez le chien non narcosé en bloc auriculo-ventriculaire chronique. J Pharmacol 13:100–101
Boucher M, Duchêne-Marullaz P, Lavarenne J (1979a) Catecholamines and cardiac rhythms in the unanesthetized dog with chronic AV block. Am J Physiol 237:H10-H17
Boucher M, Lavarenne J, Duchêne-Marullaz P (1979b) Dopamine and chronic auriculo-ventricular heart-block in the unanesthetized dog. In: Imbs JL, Schwartz J (eds) Peripheral dopaminergic receptors. Advances in the biosciences, vol 20. Pergamon Press, Oxford New York, pp 117–122
Boucher M, Dubray C, Duchêne-Marullaz P (1982a) Long-term observation of atrial and ventricular rates in the unanesthetized dog with complete atrioventricular block. Pfügers Arch 395:341–343
Boucher M, Dubray C, Duchêne-Marullaz P (1982b) Phenoxybenzamine as an antiarrhythmic agent for dopamine-induced ventricular arrhythmia in the unanesthetized chronically A-V blocked dog. IRCS Med Sci 10:706–707
Brockman SK (1965) Reflex control of the heart in complete A-V block. Am J Cardiol 16:84–92
Chassaing C, Duchêne-Marullaz P (1981) In vitro and in vivo activities of anticholinergics on the cholinoceptors of the cardiac pacemaker cells. Eur J Pharmacol 72:165–172
Chassaing C, Godenèche D, Boucher M, Duchêne-Marullaz P (1979) A comparison of changes in atropine-induced tachycardia and atropine concentration in conscious dogs. Eur J Pharmacol 58:433–441
Chawla K, Serratto M, Cruz J, Chuquimia R, Miller R, Hastrieter A, Towne WD (1977) Response to maximal and submaximal exercise testing in patients with congenital complete heart block. Circulation 55–56 [suppl III]:171
Duchêne-Marullaz P, Combre A, Lavarenne J, Boucher M, Lapalus P (1973) Le tonus cardiomodérateur s'exerce t-il sur la fréquence idioventriculaire? CR Soc Biol 167:279–282
Duchêne-Marullaz P, Combre A, Chassaing C, Delort P (1974) Observation télémétrique de la fréquence auriculaire du chien en dissociation auriculo-ventriculaire chronique. CR Soc Biol 168:300–303
Duchêne-Marullaz P, Combre A, Lavarenne J, Lapalus P, Schaff G (1975) Comparaison des effets du propranolol, de l'alprénolol, du pindolol et du practolol sur les rythmes cardiaques de chiens non narcosés en dissociation auriculoventriculaire chronique. J Pharmacol 6:441–452
Endoh M (1975) Effects of dopamine on sinus rate and ventricular contractile force of the dog heart in vitro and in vivo. Br J Pharmacol 55:475–486
Fredericq L (1904) L'atriotomie temporaire, procédé nouveau d'exploration des fonctions du coeur. Arch Int Physiol 1:83–85
Fredericq L (1911) Dissociation par compression graduée des voies motrices et arrestatrices contenues dans le faisceau de His. Arch Int Physiol 11:405–407
Harrison DC, Pirages S, Robison SC, Wintroub BU (1969) The pulmonary and systemic circulatory response to dopamine infusion. Br J Pharmacol 37:618–626
Hordof AJ, Rose E, Danilo P Jr, Rosen MR (1982) Alpha- and beta-adrenergic effects of epinephrine on ventricular pacemakers in dogs. Am J Physiol 242:H677-H682
Hsieh YY, Goldberg LI (1979) Hemodynamic consequences of administration of phentolamine or nitroprusside with dopamine in the dog. J Cardiovasc Pharmacol 1:379–388
Imanaga I, Kaneda T, Miyakawa N (1979) Comparison of the effects of dobutamine with dopamine and isoproterenol on inotropism and chronotropism in the mammalian heart. Folia Pharmacol Jpn 75:147–157
Jacobowitz D, Cooper T, Barner HB (1967) Histochemical and chemical studies of the localization of adrenergic and cholinergic nerves in the normal and denervated cat hearts. Circ Res 20:289–298
James TN, Spence CA (1966) Distribution of cholinesterase within the sinus node and A-V node of the human heart. Anat Rec 155:151–162
James TN, Bear ES, Lang KF, Green EW, Winkler HH (1970) Adrenergic mechanisms in the sinus node. Arch. Int Med 125:512–547
Kent KM, Epstein SE, Cooper T, Jacobowitz DM (1974) Cholinergic innervation of the canine and human ventricular conducting system. Anatomic and electrophysiologic correlations. Circulation 50:948–955
Maxwell GM, Rowe GG, Castillo CA, Clifford JE, Alphonso S, Crumpton CW (1960) The effect of dopamine (3-hydroxytyramine) upon the systemic, pulmonary and cardiac haemodynamic and metabolism of the intact dog. Arch Int Pharmacodyn 49:62–70
McDonald RH Jr, Goldberg LI (1963) Analysis of the cardiovascular effects of dopamine in the dog. J Pharmacol Exp Ther 140:60–66
Nickerson M, Nomaguchi GM (1949) Mechanism of dibenamine protection against cycloproprane-epinephrine cardiac arrhythmias. J Pharmacol Exp Ther 95:1–11
O'Rourke R, Kasper R, Bishop V (1973) Comparative effects of dopamine, norepinephrine and isoproterenol on left ventricular function. Clin Res 21:239
Reynolds RD, Di Salvo J (1978) Effects of dl-propranolol on atrial and ventricular rates in unanesthetized atrioventricular blocked dogs. J Pharmacol Exp Ther 205:374–381
Robinson JL, Farr WC, Grupp G (1973) Atrial rate response to ventricular pacing in the unanesthetized A-V blocked dog. Am J Physiol 224:40–45
Rolett EL, Black WL (1966) Comparison of the chronotropic action of dopamine and norepinephrine infused directly into the sinus node artery. Circulation 34 [suppl III]:200
Roskoski R Jr, Mayer HE, Schmid PG (1974) Choline acetyltransferase activity in guinea-pig heart in vitro. J Neurochem 23:1197–1200
Rossum JM Van (1966) The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch Int Pharmacodyn 160:492–494
Schmid PG, Greif BJ, Lund DD, Roskoski R Jr (1978) Regional choline acetyltransferase activity in the guinea pig heart. Circ Res 42:657–660
Setler PE, Pendleton RG, Finlay E (1975) The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs. J Pharmacol Exp Ther 192:702–712
Sheridan DJ, Penkoske PA, Sobel BE, Corr PB (1980) Alpha-adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats. J Clin Invest 65:161–171
Spear JF, Moore EN (1973) Influence of brief vagal and stellate nerve stimulation on pacemaker activity and conduction within the atrioventricular conduction system of the dog. Circ Res 32:27–41
Srivastava RD, Bhatnagar VM, Bhargava T, Dayal A (1980) Phenoxybenzamine and phentolamine as antiarrhythmic agents for spontaneous or catecholamine evoked arrhythmias in coronary occluded dog heart. Ind J Med Res 71:135–143
Vassalle M, Caress DL, Slovin AJ, Stuckey JH (1967) On the cause of ventricular asystole during vagal stimulation. Circ Res 20:228–241
Winkler RB, Freed MD, Nadas AS (1980) Exercise-induced ventricular ectopy in children and yound adults with complete heart block. Am Heart J 99:87–92
Yeh BK, McNay JL, Goldberg LI (1969) Attenuation of dopamine renal and mesenteric vasodilatation by haloperidol: evidence for a specific dopamine receptor. J Pharmacol Exp Ther 168:303–309
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boucher, M., Dubray, C. & Duchêne-Marullaz, P. Dopamine in the conscious dog with chronic heart-block. Naunyn-Schmiedeberg's Arch. Pharmacol. 326, 148–154 (1984). https://doi.org/10.1007/BF00517312
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00517312